Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the Mutanome.
Methods in molecular biology, January 2017
Mustafa Diken, Mathias Vormehr, Christian Grunwitz, Sebastian Kreiter, Özlem Türeci, Ugur Sahin
Thomas Kramps, Knut Elbers
Cancer accumulates 10s to 1000s of genomic mutations of which a fraction is immunogenic and may serve as an Achilles' heel of tumor cells. Mutation-specific T cells can recognize these antigens and destroy malignant cells. Strategies to immunotherapeutically address individual tumor mutations employing peptide or mRNA based vaccines are now actively investigated in mice and humans. An important step of determining the therapeutic potential of a mutanome vaccine is the detection of mutation reactive T-cell responses. In this chapter we provide protocols to identify and subtype mutation specific T cells in mice based on IFN-γ ELISpot and flow cytometry.
|Readers by professional status||Count||As %|
|Student > Ph. D. Student||6||18%|
|Student > Master||6||18%|
|Student > Bachelor||2||6%|
|Readers by discipline||Count||As %|
|Immunology and Microbiology||6||18%|
|Agricultural and Biological Sciences||6||18%|
|Biochemistry, Genetics and Molecular Biology||4||12%|
|Pharmacology, Toxicology and Pharmaceutical Science||3||9%|